SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-038614
Filing Date
2019-08-08
Accepted
2019-08-08 17:01:51
Documents
45
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv526125_10q.htm 10-Q 623062
2 EXHIBIT 10.1 tv526125_ex10-1.htm EX-10.1 256118
3 EXHIBIT 31.1 tv526125_ex31-1.htm EX-31.1 10392
4 EXHIBIT 31.2 tv526125_ex31-2.htm EX-31.2 10374
5 EXHIBIT 32.1 tv526125_ex32-1.htm EX-32.1 4073
6 EXHIBIT 32.2 tv526125_ex32-2.htm EX-32.2 4000
  Complete submission text file 0001144204-19-038614.txt   3389033

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ckpt-20190630.xml EX-101.INS 637824
8 XBRL TAXONOMY EXTENSION SCHEMA ckpt-20190630.xsd EX-101.SCH 32434
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ckpt-20190630_cal.xml EX-101.CAL 18365
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ckpt-20190630_def.xml EX-101.DEF 126816
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ckpt-20190630_lab.xml EX-101.LAB 215576
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ckpt-20190630_pre.xml EX-101.PRE 203810
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38128 | Film No.: 191010429
SIC: 2834 Pharmaceutical Preparations